ReEmerge says it raised $37M to test a brain implant for chronic TBI
Nicholas Schiff and Jaimie Henderson are turning a five-patient thalamic stimulation study into a clinical program enrolling up to 40 people.
By RuntimeWire Staff · Published
Primary source: PR Newswire via Yahoo Finance
Why it matters
ReEmerge is putting $37 million behind the leap from a five-patient academic result to a multicenter test. Success would open a restorative treatment path for chronic TBI; the current evidence remains preliminary and invasive.
Nicholas Schiff and Jaimie Henderson are taking ReEmerge out of stealth with a company-reported $37 million Series A and a plan to test whether deep brain stimulation can restore cognitive function years after a traumatic brain injury.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.